{
    "ticker": "ABOS",
    "name": "Averna Biosciences, Inc.",
    "description": "Averna Biosciences, Inc. is a biotechnology company dedicated to advancing the field of precision medicine through innovative diagnostic solutions. Founded in 2010, Averna focuses on the development of cutting-edge technologies that enable the detection and monitoring of diseases at a molecular level. The company specializes in biomarker discovery, assay development, and the commercialization of diagnostic tests that provide actionable insights for personalized treatment strategies. Averna's flagship product line includes state-of-the-art liquid biopsy tests that empower healthcare providers to make informed decisions based on a patient's unique genetic profile. With a commitment to scientific excellence and patient care, Averna collaborates with leading research institutions and healthcare organizations to drive forward the integration of genomics into routine clinical practice. As part of its mission, Averna aims to improve patient outcomes by delivering accurate, timely, and accessible diagnostic solutions that meet the evolving needs of the healthcare landscape.",
    "industry": [
        "Biotechnology",
        "Healthcare"
    ],
    "headquarters": "Cambridge, Massachusetts, USA",
    "founded": "2010",
    "website": "https://www.averna.com",
    "ceo": "Dr. Jennifer Smith",
    "social_media": {
        "twitter": "https://twitter.com/AvernaBiosci",
        "linkedin": "https://www.linkedin.com/company/averna-biosciences/"
    },
    "investor_relations": "https://ir.averna.com",
    "key_executives": [
        {
            "name": "Dr. Jennifer Smith",
            "position": "CEO"
        },
        {
            "name": "Michael Chen",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Diagnostic Tests",
            "products": [
                "Liquid Biopsy Test",
                "Genetic Profiling Assay"
            ]
        },
        {
            "category": "Research Services",
            "products": [
                "Biomarker Discovery",
                "Assay Development"
            ]
        }
    ],
    "seo": {
        "meta_title": "Averna Biosciences, Inc. | Precision Medicine and Diagnostic Solutions",
        "meta_description": "Explore Averna Biosciences, Inc., a leader in biotechnology focused on precision medicine and innovative diagnostic solutions. Discover our products, mission, and impact on healthcare.",
        "keywords": [
            "Averna Biosciences",
            "Biotechnology",
            "Precision Medicine",
            "Liquid Biopsy",
            "Genetic Testing",
            "Diagnostics"
        ]
    },
    "faq": [
        {
            "question": "What does Averna Biosciences specialize in?",
            "answer": "Averna Biosciences specializes in precision medicine and innovative diagnostic solutions, particularly in liquid biopsy tests."
        },
        {
            "question": "Who is the CEO of Averna Biosciences?",
            "answer": "Dr. Jennifer Smith is the CEO of Averna Biosciences, Inc."
        },
        {
            "question": "Where is Averna Biosciences headquartered?",
            "answer": "Averna Biosciences is headquartered in Cambridge, Massachusetts, USA."
        },
        {
            "question": "What are Averna's main products?",
            "answer": "Averna's main products include liquid biopsy tests and genetic profiling assays."
        },
        {
            "question": "When was Averna Biosciences founded?",
            "answer": "Averna Biosciences was founded in 2010."
        }
    ],
    "competitors": [
        "EXAS",
        "NTRA",
        "ARCH"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "BMY",
        "JNJ"
    ]
}